Literature DB >> 34142853

Progressive Multifocal Leukoencephalopathy in Children with Primary and Secondary Immune Deficiency.

Asuman Demirbuğa1, Ozge Kaba1, Selda Hançerli Törün1, Edibe Pembegül Yıldız2, Esra Yücel3, Ayper Somer1.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system that is caused by John Cunningham virus (JCV). It occurs almost exclusively in immunosuppressed individuals, for example, patients with AIDS and hematological and lymphoreticular malignancies. In this article, we present a review of the literature and 2 case reports with PML. The first report examines a 15-year-old male (who presented with dedicator of cytokinesis 8 deficiency) who was diagnosed as having PML based on characteristic magnetic resonance imaging (MRI) lesions and a positive PCR for JCV in cerebrospinal fluid. He was transferred for bone marrow transplantation after stabilization with therapy of maraviroc and cidofovir. The second report examines a 6-year-old male who presented with encephalitis and was also diagnosed with AIDS. He was diagnosed with PML and started treatment with cidofovir. His clinical status and MRI findings deteriorated rapidly. In immunosuppressive patients who developed encephalopathy, JCV ought to be considered.

Entities:  

Keywords:  HIV; JCV; progressive multifocal leukoencephalopathy

Mesh:

Substances:

Year:  2021        PMID: 34142853      PMCID: PMC8664112          DOI: 10.1089/ped.2020.1330

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol Pulmonol        ISSN: 2151-321X            Impact factor:   0.885


  13 in total

Review 1.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

2.  Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.

Authors:  David M Moore; Ross Harris; Viviane Lima; Bob Hogg; Margaret May; Benita Yip; Amy Justice; Amanda Mocroft; Peter Reiss; Fiona Lampe; Geneviève Chêne; Dominique Costagliola; Luigia Elzi; Michael J Mugavero; Antonella D'Arminio Monforte; Caroline Sabin; Daniel Podzamczer; Gerd Fätkenheuer; Schlomo Staszewski; John Gill; Jonathan A C Sterne
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11-01       Impact factor: 3.731

3.  Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Henry Masur; John T Brooks; Constance A Benson; King K Holmes; Alice K Pau; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

Review 4.  Favorable outcome after withdrawal of immunosuppressant therapy in progressive multifocal leukoencephalopathy after renal transplantation: case report and literature review.

Authors:  Hiroya Ohara; Hiroshi Kataoka; Kazuo Nakamichi; Masayuki Saijo; Satoshi Ueno
Journal:  J Neurol Sci       Date:  2014-04-02       Impact factor: 3.181

5.  Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.

Authors:  Nina Khanna; Luigia Elzi; Nicolas J Mueller; Christian Garzoni; Matthias Cavassini; Christoph A Fux; Pietro Vernazza; Enos Bernasconi; Manuel Battegay; Hans H Hirsch
Journal:  Clin Infect Dis       Date:  2009-05-15       Impact factor: 9.079

Review 6.  Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.

Authors:  Dejan Pavlovic; Andriani C Patera; Fredrik Nyberg; Marianne Gerber; Maggie Liu
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

7.  Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.

Authors:  Andrea De Luca; Adriana Ammassari; Patrizio Pezzotti; Paola Cinque; Jacques Gasnault; Juan Berenguer; Simona Di Giambenedetto; Antonella Cingolani; Yassine Taoufik; Pilar Miralles; Christina M Marra; Andrea Antinori
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

8.  Maraviroc Failed to Control Progressive Multifocal Leukoencephalopathy-Associated IRIS in a Patient with Advanced HIV Infection.

Authors:  Mónica Rodríguez; Fernando Antonio Silva-Sánchez; César Luna-Rivero; Ricardo Vega-Barrientos; Claudia Alvarado-de la Barrera; Gustavo Reyes-Terán
Journal:  Case Rep Med       Date:  2014-12-23

Review 9.  Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions.

Authors:  Abigail L Atkinson; Walter J Atwood
Journal:  Viruses       Date:  2020-09-01       Impact factor: 5.048

Review 10.  Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.

Authors:  Irene Cortese; Daniel S Reich; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2020-11-20       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.